Avenda Health | Treating prostate cancer in the clinic while preserving quality of life.

Tens of thousands of men each year with prostate cancer seek treatments that impact their quality of life with significant risks of urinary or sexual dysfunction.

At Avenda Health, we believe patients should not have to choose between treating their prostate cancer and keeping their quality of life.

Our proprietary system uses a laser to precisely treat prostate tumors without compromising urinary or sexual function. Treatments are planned and confirmed in real-time using our proprietary sensor and machine learning algorithm.

*This is an investigational device not currently available for clinical use.

The Avenda Health platform delivers targeted treatment through focal laser ablation, minimizing the impact to healthy tissue.

Plan

Intelligent Margin Prediction

Treat

Real-time Feedback and Control

Confirm

Precise Ablation

Our world class team of biomedical innovators.

Shyam Natarajan, PhD

Founder / CEO

PhD in Biomedical Engineering from UCLA
Adjunct Assistant Professor of UCLA Urology, Surgery, and Biomedical Engineering
Background in image-guided diagnosis/therapy, embedded systems, and signal processing

Leonard S. Marks, MD

Founder / CMO

Professor and deKernion Endowed Chair of Urology at UCLA
Expert in Targeted Prostate Biopsy, Active Surveillance, and Focal Therapy

Brittany Berry-Pusey, PhD

Founder / COO

PhD in Biomedical Physics UCLA School of Medicine
UCLA Anderson School of Management and Stanford Graduate School of Business training
Background in Medical Device development, digital health, pharma

Joshua Shubert

Software Engineer

M.S. in Electrical Engineering from Johns Hopkins
Industry experience in cloud-based medical software
Background in medical imaging, robotics, and global health

Jeremy Bong

Software Engineer

B.S. in Computer Science at University of Waterloo
Background in cloud architecture and full-stack
9+ years experience in professional software developement

1st Place in Los Angeles MedTech Innovator Competition, and selected for MedTech Innovator accelerator program (20 of 600 companies).

Grand Prize Winner at the 2019 SPIE Startup Challenge.

“Improving margin prediction with machine learning” honored as Best Paper at the 2019 Engineering and Urology Society meeting.

Selected for the nVidia Inception Deep Learning Incubator program

Focal Laser Ablation of Prostate Cancer

Phase I clinical trial on feasibility of outpatient laser therapy.

Journal of Urology